Polycystic ovaries are a common finding in untreated female to male transsexuals

  title={Polycystic ovaries are a common finding in untreated female to male transsexuals},
  author={Adam H Balen and M Schachter and Don Montgomery and Russell Reid and Howard S. Jacobs},
  journal={Clinical Endocrinology},
OBJECTIVE We studied the pretreatment hormone profile and ovarian ultrasound appearance of female‐to‐male transsexuals. 

Ovarian cancer in female-to-male transsexuals: report of two cases.

Simultaneous salpingo-oophorectomy should be performed in any female-to-male transsexual undergoing hysterectomy in the course of gender-confirming therapy, hypothesized to constitute an additional risk factor in transsexuals as it has been associated with ovarian epithelian cancer.

Ovulation and the Polycystic Ovary Syndrome

  • R. Jansen
  • Biology, Medicine
    The Australian & New Zealand journal of obstetrics & gynaecology
  • 1994
Once among the most treatable causes of infertility, ovulation‐induction for PCOS remained unsophisticated while microsurgery and assisted conception dissolved frontiers for other Causes of infertility.

Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan.

The sex ratio among Japanese transsexuals is different than among Caucasians, and PCOS and insulin resistance are common findings in FTM transsexual patients at initial presentation.

A Unifying Concept for Polycystic Ovary Syndrome

This chapter first discusses the nomenclature of the disorder and what the disorder should be called, and a hypothesis is presented in an attempt to unify various concepts and reconcile the differences presented by the many investigators who have studied the disorder.

Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.

The range of treatment used by transsexual people, the rationale behind these, and the expectation from such treatment are discussed, as well as the potential adverse effects of cross-sex hormone treatment of transsexual people.

Polycystic ovary syndrome

A higher rate of hyperandrogenic disorders in female-to-male transsexuals

Oocyte retrieval outcomes among adolescent transgender males

Adolescent transgender males have an excellent response to ovulation stimulation before initiating testosterone treatment, and oocyte cryopreservation is a feasible and effective way for them to preserve their fertility for future biological parenting.



Pathogenesis and treatment of polycystic ovary syndrome.

  • T. Mckenna
  • Medicine, Biology
    The New England journal of medicine
  • 1988
A large number of patients with polycystic ovary syndrome are diagnosed with atypical ovary prolapse preoperatively, and the prognosis is generally considered to be good.

Endocrine evaluation of forty female-to-male transsexuals: Increased frequency of polycystic ovarian disease in female transsexualism

Female transsexuals have an increased incidence of endocrine dysfunction which should be investigated prior to hormonal treatment, and plasma levels of testosterone, prolactin, LH/FSH ratio, and dehydroepiandrosterone sulfate were significantly increased in 30 female transsexuals prior to testosterone treatment when compared to normal adult female controls studied in the early follicular phase of the menstrual cycle.


This paper reports an analysis of the clinical, endocrine and ultrasound data within a population of 556 patients with ultrasound‐diagnosed polycystic ovaries to illustrate the limitations in the use of specific clinical or endocrine criteria as requirements for the diagnosis of the poly Cystic ovary syndrome.

Polycystic ovaries and polycystic ovary syndrome.

  • H. Jacobs
  • Medicine
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 1987
The present account is written with the clearly declared bias that women with the Stein-Leventhal syndrome suffer from a primary disturbance of their ovaries and that abnormalities of, say, gonadotropin secretion—and, by implication, of hypothalamic-pituitary function—are secondary to the ovarian lesion and not causal.

Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals.

The data suggest that increased blood levels and presumably increased ovarian concentrations of testosterone may produce the morphological features of polycystic ovarian disease.

Ovarian morphology in long‐term androgen‐treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?

It is demonstrated that androgens alone may induce polycystic changes in women with transsexualism and the assumption that the role of androgens is pivotal at the follicular level—inducing follicle growth arrest and accelerating cystic changes—in the genesis ofpolycystic ovaries is reinforced.

The Prevalence of Transsexualism in England and Wales

The incidence and prevalence of transsexualism are difficult to establish, as the syndrome is not sufficiently common to lend itself to the usual methods of epidemiological research.